Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss

Sponsor
Duke University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04739436
Collaborator
Patient-Centered Outcomes Research Institute (Other)
350
2
2
24.1
175
7.2

Study Details

Study Description

Brief Summary

This study aims to evaluate the benefit of bilateral hearing aid use compared to a unilateral hearing aid. Patients with mild to moderate bilateral hearing loss who are considering the purchase of a commercially available hearing aid will be considered for participation. Eligible participants will be randomized to one of the following treatment arms: (1) a bilateral hearing aid fitting group, and (2) a unilateral hearing aid fitting group.

Condition or Disease Intervention/Treatment Phase
  • Device: Hearing amplification
N/A

Detailed Description

Primary objectives:
  1. To compare the hearing-aid benefit of unilateral versus bilateral fittings of commercially-available hearing aids that incorporate a dome coupling (open or closed dome as required by degree of hearing loss, or custom coupling if clinically indicated), which represents the most popular style used for mild to moderate hearing loss.

  2. To compare other multi-dimensional outcomes including hearing-related quality of life, hearing aid satisfaction in patient-nominated goals, ecological hearing aid outcomes, and hearing aid use.

Secondary objectives:
  1. To compare performance outcomes for unilateral versus bilateral hearing aid fittings

  2. To explore the differences in long-term patient reported outcomes for their final hearing aid configuration choice

  3. To explore patient experiences in each group (unilateral vs bilateral), and patient preference in regards to their choice of final hearing aid configuration.

This study is being conducted at Duke and Vanderbilt Medical Centers, with Duke functioning as the main coordinating center. Study participants will pay out of pocket for the hearing aid(s), but will be able to extend the hearing aid fitting trial period from 60 days (standard of care) to 180 days (6 months). Participants will be given the opportunity to change their hearing aid configuration and/or return their hearing aid(s) for a refund after 3 months, and again at the end of the 6 month study period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
350 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss
Actual Study Start Date :
Apr 26, 2021
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Bilateral hearing aid fitting group

Device: Hearing amplification
Bilateral vs. unilateral hearing aids for hearing loss

Active Comparator: Unilateral hearing aid fitting group

Device: Hearing amplification
Bilateral vs. unilateral hearing aids for hearing loss

Outcome Measures

Primary Outcome Measures

  1. Change in Hearing Aid Benefit [Baseline, 3 months, 6 months]

    Measured by Abbreviated Profile of Hearing Aid Benefit (APHAB)

Secondary Outcome Measures

  1. Change in Hearing Aid Benefit [3 months, 6 months]

    Measured by Ecological Momentary Assessment (EMA) with in-situ Glasgow Hearing Aid Benefit Profile (GHABP)

  2. Change in Hearing Aid Benefit as measured by speech in noise performance [Baseline, 3 months]

    Bamford -Kowal-Bench speech in noise (BKB SIN) test

  3. Change in Hearing Aid Benefit as measured by Auditory Working Memory [Baseline, 3 months]

    Abbreviated Word Auditory Recognition and Recall Measure (WARRM)

  4. Change in Hearing Aid Satisfaction [3 months , 6 months]

    Measured by Satisfaction with Amplification in Daily Life (SADL) survey completion

  5. Hours of Hearing Aid Use [1 month]

    Measured by automated data log extracted from hearing aid

  6. Hours of Hearing Aid Use [3 months]

    Measured by automated data log extracted from hearing aid

  7. Change in Hearing Related Quality Life [Baseline, 3 months, 6 months]

    Measured by Hearing Handicap Inventory for Elderly (HHIE) survey completion

  8. Change in complex ecological listening [Baseline, 3 months, 6 months]

    Measured by Speech Spatial Qualities (SSQ) survey completion

  9. Hearing aid expectations [Baseline]

    Measured by Expected Consequences of Hearing Aid Ownership (ECHO) survey completion

  10. Change in global hearing aid outcomes [3 months, 6 months]

    Measured by International Outcome Inventory for Hearing aids (IOI_HA) survey completion

  11. Experience with hearing aid assignment [3 months]

    Measured by a self-reported questionnaire using a 10 point scale (1 = not at all and 10 is very highly likely/full recommendation)

  12. Experience with hearing aid assignment [3 months]

    Measured by open ended questions and discussion during a participant focus group

  13. Number of participants in each arm that chose 0 hearing aids as measured by patient preference [3 months]

    Measured by participant's final choice of 0, 1, or 2 hearing aids

  14. Number of participants in each arm that chose 1 hearing aid as measured by patient preference [3 months]

    Measured by participant's final choice of 0, 1, or 2 hearing aids

  15. Number of participants in each arm that chose 2 hearing aids as measured by patient preference [3 months]

    Measured by participant's final choice of 0, 1, or 2 hearing aids

  16. Preference with hearing aid assignment [3 months]

    Measured by open ended questions and discussion during a participant focus group

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 50+ years of age

  • Ability to read and understand English

  • Mild to moderate sensorineural hearing loss (defined by a pure-tone average at 500, 1000, and 2000 Hz of <55 dB HL in each ear, and the 3000 Hz and 4000 Hz threshold <80 in each ear), based on a hearing test obtained within the last 6 months by a licensed audiologist.

  • Symmetrical hearing loss defined by <20 dB difference between the pure-tone average of 500, 1000, and 2000 Hz between ears)

  • Interested in purchasing hearing aids, but is open minded about trying one or two hearing aids

  • No prior hearing aid use longer than 3 months (as documented via self-report)

  • Adequate literacy to complete questionnaires

  • Willing to purchase study-specific hearing aid(s)

  • Access to a smart phone and the internet

Exclusion Criteria:
  • Concerns for middle ear pathology (e.g., air bone gap of >15 dB at 2 consecutive octave frequencies in either ear)

  • Concerns for retrocochlear pathology by audiologist (e.g unilateral tinnitus or ear fullness, referral to ENT/Auditory Brainstem Response testing to r/o acoustic neuroma)

  • Severe tinnitus as the reason for seeking amplification

  • Co-morbid condition that would interfere with study (e.g., dementia, blindness, neurologic pathology)

  • History of fluctuating hearing loss

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27710
2 Vanderbilt University Medical Center Nashville Tennessee United States 37232

Sponsors and Collaborators

  • Duke University
  • Patient-Centered Outcomes Research Institute

Investigators

  • Principal Investigator: Sherri Smith, AuD,PhD, Duke Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT04739436
Other Study ID Numbers:
  • Pro00106077
  • PCORI-HL-2019C1-16059
First Posted:
Feb 4, 2021
Last Update Posted:
May 27, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2022